Cytokeratin intermediate filament expression in benign and malignant breast disease. - Wikidata - awgldk - TriplyDB

Cytokeratin intermediate filament expression in benign and malignant breast disease.

Cytokeratin intermediate filament expression in benign and malignant breast disease.

http://www.wikidata.org/entity/Q37255237

about

Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies.A novel platform for detection of CK+ and CK- CTCs.Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins.The Immunohistochemical Expression of the Oestrogen Receptor (ER), HER-2/NEU and Cytokeratin 8/18 and 5/6 in Invasive Breast Carcinoma Classification of breast carcinomas according to gene expression profiles The cytokeratin profile of medullary carcinoma of the breast.Progesterone stimulates proliferation and promotes cytoplasmic localization of the cell cycle inhibitor p27 in steroid receptor positive breast cancers.Progesterone decreases levels of the adhesion protein E-cadherin and promotes invasiveness of steroid receptor positive breast cancers.CD109 expression in basal-like breast carcinoma.Atypical ductal hyperplasia: interobserver and intraobserver variability.

P2860

Q34286198-F307A213-819C-46B5-8850-27CF630F5715 Q35612329-D0D06CAE-922C-4040-A203-8780F6AEFF3D Q35749421-1C9C719F-EB77-4B01-ACB5-3C8F3056FDAD Q36136536-954B791F-67F6-42AE-85EE-7C1748BE07F0 Q36481375-1529B4AB-59A3-4DB6-B06E-E4AC42C31CC3 Q36760781-627D7415-6442-476C-9538-8A0E1052A3EB Q38464251-0B0AD7AA-CECE-45F5-BCC5-B0BC7C9F5C3F Q39101500-B3BC900B-542C-449A-BF7B-D206845AEB53 Q39101505-11B06046-A7A0-42B9-8D34-68FF4351F921 Q42170620-57C04F06-9AA2-4538-9EFB-BEAF1AFC575A Q50630965-FEFEB71D-075A-4453-B692-CC21777F96E5

P2860

Cytokeratin intermediate filament expression in benign and malignant breast disease.

http://www.wikidata.org/entity/Q37255237

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 1995

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cytokeratin intermediate filament expression in benign and malignant breast disease.

@en

Cytokeratin intermediate filament expression in benign and malignant breast disease.

@nl

type

label

Cytokeratin intermediate filament expression in benign and malignant breast disease.

@en

Cytokeratin intermediate filament expression in benign and malignant breast disease.

@nl

prefLabel

Cytokeratin intermediate filament expression in benign and malignant breast disease.

@en

Cytokeratin intermediate filament expression in benign and malignant breast disease.

@nl

P1433

Q37255237-4A6A7A18-63A2-4F09-ACEE-80939D8129BC

P1476

Q37255237-19D54434-5A0D-46B7-9750-22C138BAEE2D

P2093

Q37255237-1129371C-5263-4468-BD7A-BD48761C1401

Q37255237-AF46E1CF-3E4D-4AF7-AE83-977CBDDDBE2B

Q37255237-F7688B35-AD71-4906-804B-BB4B8678611F

Q37255237-FEB93B0C-7FA5-44B4-B626-A01E0805F59B

P2860

Q37255237-08E768EF-0ABB-42D0-8B61-70F3F2939FC8

Q37255237-0FE25FEF-8875-46BA-A7C3-2846C668CD54

Q37255237-144A7609-0074-405F-ADB2-854B4DBDAD12

Q37255237-1DBDFB65-E22A-42A7-9918-82E25B158E71

Q37255237-1DCA4B6D-0CB1-4A34-B8F5-CA04464B0F3E

Q37255237-1F672711-C35F-4EF7-8EBB-9403DEE9A413

Q37255237-220FCE8A-371F-4FA8-AEB2-6487484903A7

Q37255237-2604E3DB-D631-4E9C-B879-E7E12EE429DD

Q37255237-32227A3A-4266-40CE-A45C-3A6B5BDFB26B

Q37255237-3E4EEB23-A08F-41D4-8A04-61FC21AD5B7D

P304

Q37255237-4D948B2F-836D-40E3-9854-D06B67D38BDE

P31

Q37255237-CF105C11-7B82-400A-A5CB-4C7C113D990D

P356

Q37255237-132BF881-B70F-4362-AE0D-11CB43888577

P407

Q37255237-34487485-D5E0-4479-9C24-D16E0B08CC87

P433

Q37255237-054E4BCE-0939-4442-B609-7F9EA9CF6636

P478

Q37255237-04B3F0D0-29B5-473D-BCC3-BF8145D73700

P577

Q37255237-D91EAF6E-1F34-429D-AF28-AB33197F9929

P5875

Q37255237-C5BFE69F-8062-4148-90DA-6A863A8AE30D

P698

Q37255237-56F04754-D127-40A0-A640-4060EDF89265

P932

Q37255237-7E250EEF-E9D2-43F3-B4F5-E8D5149E02E8

P356

P1433

Journal of Clinical Pathology

P1476

Cytokeratin intermediate filament expression in benign and malignant breast disease.

@en

P2093

Heatley M

http://www.w3.org/2001/XMLSchema#string

Maxwell P

http://www.w3.org/2001/XMLSchema#string

Toner P

http://www.w3.org/2001/XMLSchema#string

Whiteside C

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

Changing patterns of keratin expression during progression of cervical intraepithelial neoplasia

Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumors, dysplasias and breast cancer

Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression.

Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas.

Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast

Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast

Basal cell-specific and hyperproliferation-related keratins in human breast cancer

The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects.

P304

26-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JCP.48.1.26

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

1995-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15662917

http://www.w3.org/2001/XMLSchema#string

P698

7535804

http://www.w3.org/2001/XMLSchema#string

P932

502256

http://www.w3.org/2001/XMLSchema#string